Tandem Diabetes Care, Inc. (TNDM)
21.43
+0.03
(+0.14%)
USD |
NASDAQ |
Aug 28, 16:00
21.29
-0.14
(-0.65%)
After-Hours: 20:00
Tandem Diabetes Care Cash from Operations (Quarterly) : -34.63M for June 30, 2026
Cash from Operations (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -34.63M |
| March 31, 2026 | 11.05M |
| December 31, 2025 | 9.789M |
| September 30, 2025 | 8.264M |
| June 30, 2025 | -9.496M |
| March 31, 2025 | -18.28M |
| December 31, 2024 | 10.72M |
| September 30, 2024 | 26.78M |
| June 30, 2024 | -5.275M |
| March 31, 2024 | -7.996M |
| December 31, 2023 | -7.216M |
| September 30, 2023 | 0.055M |
| June 30, 2023 | -6.323M |
| March 31, 2023 | -18.33M |
| December 31, 2022 | 5.82M |
| September 30, 2022 | 23.94M |
| June 30, 2022 | 6.901M |
| March 31, 2022 | 13.80M |
| December 31, 2021 | 19.64M |
| September 30, 2021 | 34.14M |
| June 30, 2021 | 28.90M |
| March 31, 2021 | 28.68M |
| December 31, 2020 | 15.24M |
| September 30, 2020 | 14.56M |
| June 30, 2020 | 15.50M |
| Date | Value |
|---|---|
| March 31, 2020 | -20.63M |
| December 31, 2019 | 19.44M |
| September 30, 2019 | 23.02M |
| June 30, 2019 | 3.568M |
| March 31, 2019 | -4.124M |
| December 31, 2018 | 14.13M |
| September 30, 2018 | -3.457M |
| June 30, 2018 | -6.723M |
| March 31, 2018 | -12.27M |
| December 31, 2017 | -11.64M |
| September 30, 2017 | -19.02M |
| June 30, 2017 | -14.66M |
| March 31, 2017 | -20.81M |
| December 31, 2016 | -13.58M |
| September 30, 2016 | -18.15M |
| June 30, 2016 | -13.49M |
| March 31, 2016 | -15.94M |
| December 31, 2015 | -10.25M |
| September 30, 2015 | -14.34M |
| June 30, 2015 | -18.76M |
| March 31, 2015 | -15.42M |
| December 31, 2014 | -15.14M |
| September 30, 2014 | -13.58M |
| June 30, 2014 | -15.70M |
| March 31, 2014 | -16.96M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| DexCom, Inc. | 269.20M |
| Modular Medical, Inc. | -5.972M |
| Senseonics Holdings, Inc. | -30.14M |
| NeuroPace, Inc. | -3.903M |
| Abbott Laboratories | 2.488B |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -87.34M |
| Cash from Financing (Quarterly) | 2.154M |
| Free Cash Flow | -26.62M |
| Free Cash Flow Per Share (Quarterly) | -0.5605 |
| Free Cash Flow to Equity (Quarterly) | -43.20M |
| Free Cash Flow to Firm (Quarterly) | -36.17M |
| Free Cash Flow Yield | -1.82% |